Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Enhancing Addiction Treatment Through Psychoeducation

Official title: Enhancing Addiction Treatment Through Psychoeducation: Evaluating the Feasibility and Acceptability of a Neuroscience-Informed Mobile App

Run by Virginia Commonwealth University · NCT07178158 · Data updated 2026-11-12

A digital program tests whether neuroscience-based psychoeducation plus games can help people with opioid or stimulant use disorders who are on treatment to improve metacognition and treatment engagement.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorVirginia Commonwealth University
Academic / other
Locations1 site (Richmond, Virginia)
StatusRecruiting
StartedJuly 23, 2026
Main results expectedApril 30, 2027
Study endsApril 30, 2027
Registry record updatedAugust 7, 2026
Trial IDNCT07178158 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with current DSM-5 opioid and/or stimulant use disorder who are on medication treatment and own a smartphone.

Probably not a fit

Individuals without smartphone access, non-English speakers, or those with active psychosis, mania, or suicidal ideation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study investigates the feasibility of the NIPA program, an app-based psychoeducation and game-based cognitive training designed to raise awareness of cognitive deficits linked to substance use. The program delivers four 20-minute sessions focusing on attention, memory, cognitive flexibility, and impulsivity, with videos, animations, and adapted neurocognitive games. Participants use Metacognium software in addition to their usual treatment, with eligibility limited to adults on medication-assisted therapy for SUDs who own a compatible smartphone. The study excludes individuals with active psychosis, mania, or suicidal/homicidal ideation and non-English speakers. The primary aim is to determine feasibility and potential impact on engagement and cognitive self-awareness within standard care for SUDs.

Why it matters

Potential benefit: If successful, the program could improve treatment engagement and cognitive self-awareness, potentially supporting longer abstinence and adherence to therapy.

How similar studies have gone: Earlier similar approaches combining psychoeducation and cognitive training in SUDs have shown feasibility and signals of engagement, but this exact metacognition-focused digital platform is novel in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* current DSM-5 opioid and/or stimulant use disorder
* currently on medication treatment for SUD
* owning a smartphone with sufficient functionality to download and utilize the NIPA app.

Exclusion Criteria:

* current psychosis, mania, or suicidal/homicidal ideation
* non-English speaking

Where it's running

  • Virginia Commonwealth University
    Richmond, Virginia, United States
    Recruiting

Study contacts

  • Principal investigator: Jasmin Vassileva, Ph.D. — Virginia Commonwealth University
  • Study coordinator: Kayla McLean
  • Email: mcleankl@vcu.edu
  • Phone: (804) 828-8402

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.